4:46 PM ET
8-K
Executive Compensation
DNA X Executive Compensation
DNA X, Inc. approved a substitute cash award for acting CEO and Executive Chairman Mike Mulica in lieu of an annual RSU grant due to a lack of available shares in the company's equity incentive plan. The award is valued at $50,000 worth of 'Phantom RSUs' as of November 14, 2026, and will be settled in cash upon vesting at the 2027 annual meeting or a change in control.